Project Grant HT94252510302
Award Date
9/1/25
Completion Date
8/31/29
Dollars Obligated
$5M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43210, USA
Similar Awards
The Defense Health Agency awarded The Ohio State University a $8,375,496 cooperative agreement under the Military Medical Research and Development program (CFDA 12.420) from September 30, 2022 to September 29, 2026. This award will fund the Augmenting Suicide Prevention Interventions for Service Members project, which consists of five synergistic studies that aim to identify the strategies, delivery methods, providers, and circumstances most effective for preventing suicidality among military...
The Ohio State University will receive $1,181,604 under a four-year Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The funding will support research into developing new methods to access extracellular vesicle MDM2 DNA cargo as a potential biomarker for liposarcoma. The grant aims to transform health care for service members and the public through innovative biomedical research investigating medical solutions for...
This federal Project Grant award of $267,311 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a randomized clinical trial utilizing crisis response planning for suicide prevention in military personnel with traumatic brain injury. The award was made to The Ohio State University, which will serve as the prime recipient, with a performance period from August 1, 2024 to July 31, 2027. The project aims to...
This $3,823,679 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development and evaluation of a web-based training program for brief cognitive behavioral therapy (BCBT) for suicide prevention. The prime awardee, The Ohio State University, is collaborating with subrecipients The University of Texas Health Science Center at San Antonio, the Medical University of South Carolina, and the University of Memphis...
The Department of the Army Medical Command awarded a $3,874,682 Project Grant to The Ohio State University Office of Sponsored Programs under the Military Medical Research and Development program. The grant will fund research from July 1, 2022 to June 30, 2026 to investigate the mechanisms of metastasis suppression and develop translational applications in thyroid cancer. As part of the Military Medical Research and Development program's goal to transform military and public health through...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,181,250.00 to The Ohio State University to conduct research on the use of MIF inhibition and glucocorticoid therapeutics as a synergistic treatment to promote neuronal survival in traumatic retinal injury. The research aims to develop novel therapies for this type of injury, which is of particular relevance to military personnel. The...
The Ohio State University received a $156,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The two-year award beginning in June 2021 will support research on Fatty Acid Binding Protein-5 as a novel therapeutic target against aggressive lung cancer. Through this funding, The Ohio State University researchers will investigate medical solutions for lung cancer, advancing the Military Medical Research...
The federal Project Grant award of $1,225,245.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research initiative titled "CARDIOVASCULAR RISK PROFILING OF DEPLOYMENT-RELATED RESPIRATORY DISEASE: A TRANSLATIONAL APPROACH" at The Ohio State University. The research project aims to investigate cardiovascular risk factors associated with deployment-related respiratory diseases, with the goal of developing...
The Ohio State University received a $248,237 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award will fund a 3-year project from July 1, 2023 to June 30, 2026 to research and address traumatic brain injuries among law enforcement officers. No additional details about specific products or services to be delivered under this award were provided. The Military Medical Research and Development program supports basic,...
This federal Project Grant award from the Department of the Army's Military Medical Research and Development program (CFDA 12.420) provides $1,574,999.00 to The Ohio State University to conduct research on "SLIT2 as a novel approach for targeting metastatic breast cancer." The award, which runs from June 15, 2025 to June 14, 2028, supports advanced biomedical research aimed at transforming healthcare for military service members and the broader public. The research at The Ohio State...